Skip to content

In the BioHarmony Drug Report Database

Cetrorelix

Cetrotide (cetrorelix) is a protein pharmaceutical. Cetrorelix was first approved as Cetrotide on 1999-04-12. It is used to treat ovarian hyperstimulation syndrome in the USA. It has been approved in Europe to treat ovulation and ovulation induction. The pharmaceutical is active against gonadotropin-releasing hormone receptor.
Trade Name Cetrotide
Common Name Cetrorelix
Indication ovarian hyperstimulation syndrome, ovulation, ovulation induction
Drug Class Hormone-release inhibiting peptides
Cetrorelix
Get full access now